Top compounds associated with response to MLLT3


Feature Type Standardized
Nominal ANOVA
mRNA Fumonisin B1 CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.18 1e-07
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.18 8e-07
mRNA Imatinib CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA austocystin d CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.24 4e-06
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA compound 1B CTRPv2 pan-cancer AAC 0.16 3e-05
Download CSV